Ventus Therapeutics U.s., Inc.

This early-stage study tested whether an oral medication called VENT-02 is safe for people with mild to moderate Parkinson's disease. About 30 participants took either the drug or a placebo pill twice daily for 28 days while researchers monitored for side effects and measured inf…